Stapokibart for the Treatment of Refractory Palmoplantar Pustulosis
This case series study evaluates the effectiveness and safety of stapokibart in treating patients with refractory palmoplantar pustulosis.
Authors
- Ruilian Li (ORCID: https://orcid.org/0000-0001-9952-6093)
- Jialin Lian
- Danyang Yang
- Y-G Zhang
- Jiayi Han (ORCID: https://orcid.org/0000-0002-6654-6896)
- Zhigang Xu
- Yufei Wu
- Chenyue Liu (ORCID: https://orcid.org/0009-0000-6747-9587)
- Xiaoli Li
- Xin Liu
- Zhuokun Liu
- Zhenghui Wang
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xijing Hospital (CN)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2026-04-22
- DOI
- https://doi.org/10.1001/jamadermatol.2026.0669
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00